Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Kintor Pharma Announces First Patient Dosing in Phase II Clinical Trial of KX-826 for Treatment of Androgenic Alopecia Patients in the US 2022-03-01 20:30
PHASE II CLINICAL STUDY AT WEILL CORNELL MEDICAL CENTER INVESTIGATING PAXALISIB IN COMBINATION WITH METFORMIN AND A KETOGENIC DIET ENROLLS FIRST PATIENT 2022-02-28 21:00
PharmAbcine Announces Last Patient Last Visit in its Phase Ib mTNBC Combination Trial 2022-02-25 21:00
SeekIn Receives CE Mark Approval for SeekInCare® Pan Cancer Early Detection Test 2022-02-24 21:34
Jacobio JAB-21822 in Combination with Cetuximab Completes First Dose of Colorectal Cancer Patient in China 2022-02-24 10:32
Foresee Pharmaceuticals and TRPharm Announce License and Co-Development Agreement 2022-02-23 23:00
BIORCHESTRA Announces 45 Million USD Series C Fundraising 2022-02-23 11:26
Gracell Biotechnologies Announces Multiple Advancements of TruUCAR Allogeneic CAR-T Platform 2022-02-22 20:30
Revotek Receives Clearance from the National Health Commission of China for the World First Clinical Trial for 3D Bioprinted Stem Cell Vascular Grafts 2022-02-21 22:30
HanAll Biopharma Appoints Almira Chabi as Chief Medical Officer and Chief Development Officer 2022-02-21 22:00
Adlai Nortye Announces Publication of Preclinical Research of AN3025 (anti-hTNFR2）in Frontiers in Immunology 2022-02-21 21:00
Harbour BioMed Announces IND Approval for Next-Gen Anti-TSLP Fully Human Monoclonal Antibody 2022-02-21 20:29
Biosion, Inc. Appoints Joel Edwards, MBA, as Chief Business Officer 2022-02-21 13:00
OliPass Announces Commencement of Dosing in Phase 2a Trial for Pain Killer OLP-1002 2022-02-18 23:00
Keymed Bio Joins Hang Seng Family of Indexes 2022-02-18 22:10
PolyActiva Announces Positive Phase IIa Trial Results in Low Dose Cohort for PA5108 Ocular Implant with Prezia™ Sustained Drug Delivery Technology 2022-02-18 08:19
Gracell Biotechnologies Doses First Patients in First-in-Human Clinical Trial Evaluating GC012F, its Dual-Targeting FasTCAR-T Therapy, in B-Cell Non-Hodgkin's Lymphoma 2022-02-17 21:30
Flat Medical joins the Stay Connected(R), the International Organization for Safer Neuraxial Anesthesia 2022-02-17 21:00
PharmaBlock Appoints Dr. Zhengtian Gu as Senior Vice President of Quality and Regulatory Affairs 2022-02-16 20:00
Travecta Therapeutics Appoints Leading Experts to Expand its Scientific Advisory Leadership Team 2022-02-15 21:00
1 87 88 89 90 91 222